A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine

BACKGROUND: An inactivated quadrivalent influenza vaccine (QIV) was recently licenced in the US as a thimerosal-free formulation presented in a pre-filled syringe. A multidose presentation is preferred in some settings due to reduced acquisition and cold storage costs. We assessed the immunogenicity...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jain, Varsha K, Chandrasekaran, Vijayalakshmi, Wang, Long, Li, Ping, Liu, Aixue, Innis, Bruce L
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995899/
https://ncbi.nlm.nih.gov/pubmed/24606983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-133
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items